Company profile: Presage Biosciences
1.1 - Company Overview
Company description
- Provider of cancer drug development technology via the CIVO platform, delivering microdoses of multiple drugs to different tumor regions to observe molecular and cellular responses. Offers preclinical CIVO services to evaluate immune effects in syngeneic models across modalities, and Phase 0 clinical trials injecting microdoses into patient tumors to assess drug effects with minimal exposure.
Products and services
- CIVO Platform: Engineers a patient-specific technology delivering microdoses of multiple drugs to distinct tumor regions, enabling observation of molecular and cellular responses within the patient's tumor
- Phase 0 Clinical Trials: Conducts clinical-grade Phase 0 studies using CIVO to inject microdoses directly into a patient's tumor, generating early insights into drug effects and tumor response with minimal exposure
- Preclinical CIVO Offerings: Delivers model-driven services evaluating immune effects in syngeneic models and supporting preclinical studies across modalities, including small molecules, biologics, and novel delivery systems
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Presage Biosciences
Nanna Therapeutics
HQ: United Kingdom
Website
- Description: Provider of drug discovery platforms targeting fundamental cellular processes in age-related diseases. Offers the Nanoscale Medicines Discovery Engine for novel drugs addressing mitochondrial dysfunction and the Totally Integrated Medicines Engine (TIME), conducting 100 million phenotypic assays per hour to identify small-molecule leads for mitochondrial, neurodegenerative, cardiovascular/metabolic, joint/tissue diseases and cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanna Therapeutics company profile →
Genemed Biotechnologies
HQ: United States
Website
- Description: Provider of products aimed at improving the role of surgical pathology and personalized medicine, incorporating quality throughout.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genemed Biotechnologies company profile →
Crawford Scientific
HQ: United Kingdom
Website
- Description: Provider of chromatography consumables and products (columns, vials, syringe filters, gas generators), analytical services, and chromatography/mass spectrometry training, offering HPLC columns, technical support and consultancy, online training courses, and the CHROMacademy eLearning platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Crawford Scientific company profile →
Biopremier
HQ: Portugal
Website
- Description: Provider of molecular biology products and DNA sequencing services for the Agrifood, Environmental, Human Clinical, and Animal Health industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biopremier company profile →
Indigo Biosciences
HQ: United States
Website
- Description: Provider of nuclear receptor-focused products and services addressing therapeutic drug targets, including cell-based luciferase reporter assay kits for GPCR and nuclear receptors, Live Cell Multiplex assays to quantify live cells alongside nuclear receptor assays, INDIGlo luciferase detection reagent, environmental testing bioassays, and an ortholog assay portfolio for cross-species receptor activity comparison aiding selection of animal models for drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Indigo Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Presage Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Presage Biosciences
2.2 - Growth funds investing in similar companies to Presage Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Presage Biosciences
4.2 - Public trading comparable groups for Presage Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →